Literature DB >> 11090431

Time-dependent ovulation inhibition of a selective progesterone-receptor antagonist (Org 31710) and effects on ovulatory mediators in the in vitro perfused rat ovary.

M Pall1, M Mikuni, K Mitsube, M Brännström.   

Abstract

Progesterone (P) is one of several local mediators in the ovulatory cascade in the rat. The precise mechanisms of action for P in ovulation and in what phase of the ovulatory process P is critical, however, need to be clarified. The present study used a selective P-receptor antagonist, Org 31710, in the in vitro perfused rat ovary model to examine the local role of P and possible effects on prostaglandin (PG) and plasminogen-activator (PA) release in ovulation. Ovaries from eCG (15 IU)-primed rats were perfused for 20 h with LH (0.2 microg/ml) and 3-isobutyl-1-methylxanthine (IBMX, 200 microM) to induce ovulation (median = 10.0, 25%-75% range = 8.5-13). Org 31710 was added at either 0, 3.5, 7, or 9 h after LH+IBMX, resulting in significant suppression of ovulation after addition at 0 and 3.5 h (1.0, 1-5.5; and 5.0, 2.5-7.75 ovulations, respectively) but no suppressive effect when added at later time points. Progesterone and estradiol levels in the perfusion media were increased after LH+IBMX but were not affected by the presence of Org 31710. Ovarian tissue levels of PGE(2), PGF(2 alpha), and PA activity were measured in ovaries that had been perfused for 10 h, a time that was 2 to 5 h before anticipated ovulation. The presence of Org 31710 significantly decreased the levels of PGE(2), PGF(2 alpha), and PA activity. These results suggest that P is essential in ovulation during the initial stages of the ovulatory process. The effect of P to facilitate ovulation seems to relate to stimulation of the PG- and PA-mediator systems.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090431     DOI: 10.1095/biolreprod63.6.1642

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  8 in total

Review 1.  Local role of progesterone in the ovary during the periovulatory interval.

Authors:  Charles L Chaffin; Richard L Stouffer
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

2.  X-linked lymphocyte regulated gene 5c-like (Xlr5c-like) is a novel target of progesterone action in granulosa cells of periovulatory rat ovaries.

Authors:  Birendra Mishra; Ji Yeon Park; Kalin Wilson; Misung Jo
Journal:  Mol Cell Endocrinol       Date:  2015-05-21       Impact factor: 4.102

Review 3.  Non-canonical progesterone signaling in granulosa cell function.

Authors:  John J Peluso; James K Pru
Journal:  Reproduction       Date:  2014-04-08       Impact factor: 3.906

Review 4.  Ovulation: Parallels With Inflammatory Processes.

Authors:  Diane M Duffy; CheMyong Ko; Misung Jo; Mats Brannstrom; Thomas E Curry
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

5.  Relevance of an opioid, noscapine in reducing cystogeneses in rat experimental model of polycystic ovary syndrome.

Authors:  A Priyadarshani
Journal:  J Endocrinol Invest       Date:  2009-07-17       Impact factor: 4.256

6.  Coordinated Regulation Among Progesterone, Prostaglandins, and EGF-Like Factors in Human Ovulatory Follicles.

Authors:  Yohan Choi; Kalin Wilson; Patrick R Hannon; Katherine L Rosewell; Mats Brännström; James W Akin; Thomas E Curry; Misung Jo
Journal:  J Clin Endocrinol Metab       Date:  2017-06-01       Impact factor: 5.958

Review 7.  Control of oocyte release by progesterone receptor-regulated gene expression.

Authors:  Rebecca L Robker; Lisa K Akison; Darryl L Russell
Journal:  Nucl Recept Signal       Date:  2009-12-31

8.  Immature rats show ovulatory defects similar to those in adult rats lacking prostaglandin and progesterone actions.

Authors:  María Gaytan; Carmen Bellido; Concepcion Morales; Marcelino Gonzalez-Padilla; Jose E Sanchez-Criado; Francisco Gaytan
Journal:  Reprod Biol Endocrinol       Date:  2004-09-03       Impact factor: 5.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.